Tuesday, April 30, 2019

Vividion Therapeutics Raises $82M More

San Diego-based Vividion Therapeutics, a biopharmaceuticals startup working on small molecule drugs, hsa raised $82M in a Series B funding round, the company said this morning. The funding--which the company said was oversubscribed--was led by Nextech Invest, and also included BVF Partners, Casdin Capital, Mubadala Ventures, Trinitas Capital, Mirae Asse

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.